SE0202279D0 - Novel comppounds - Google Patents

Novel comppounds

Info

Publication number
SE0202279D0
SE0202279D0 SE0202279A SE0202279A SE0202279D0 SE 0202279 D0 SE0202279 D0 SE 0202279D0 SE 0202279 A SE0202279 A SE 0202279A SE 0202279 A SE0202279 A SE 0202279A SE 0202279 D0 SE0202279 D0 SE 0202279D0
Authority
SE
Sweden
Prior art keywords
sup
comppounds
novel
compounds
prophylaxis
Prior art date
Application number
SE0202279A
Other languages
English (en)
Swedish (sv)
Inventor
Antonio Mete
Iain Walters
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0202279A priority Critical patent/SE0202279D0/xx
Publication of SE0202279D0 publication Critical patent/SE0202279D0/xx
Priority to AU2003245230A priority patent/AU2003245230A1/en
Priority to AT03738863T priority patent/ATE382616T1/de
Priority to JP2004522890A priority patent/JP2006504655A/ja
Priority to ES03738863T priority patent/ES2297174T3/es
Priority to EP03738863A priority patent/EP1539731B9/en
Priority to US10/521,727 priority patent/US20050203172A1/en
Priority to PCT/SE2003/001215 priority patent/WO2004009580A1/en
Priority to DE60318459T priority patent/DE60318459T2/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0202279A 2002-07-19 2002-07-19 Novel comppounds SE0202279D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0202279A SE0202279D0 (sv) 2002-07-19 2002-07-19 Novel comppounds
AU2003245230A AU2003245230A1 (en) 2002-07-19 2003-07-15 Novel compounds
AT03738863T ATE382616T1 (de) 2002-07-19 2003-07-15 Neue verbindungen
JP2004522890A JP2006504655A (ja) 2002-07-19 2003-07-15 新規化合物
ES03738863T ES2297174T3 (es) 2002-07-19 2003-07-15 Nuevos compuestos.
EP03738863A EP1539731B9 (en) 2002-07-19 2003-07-15 Novel compounds
US10/521,727 US20050203172A1 (en) 2002-07-19 2003-07-15 Novel compounds
PCT/SE2003/001215 WO2004009580A1 (en) 2002-07-19 2003-07-15 Novel compounds
DE60318459T DE60318459T2 (de) 2002-07-19 2003-07-15 Neue verbindungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202279A SE0202279D0 (sv) 2002-07-19 2002-07-19 Novel comppounds

Publications (1)

Publication Number Publication Date
SE0202279D0 true SE0202279D0 (sv) 2002-07-19

Family

ID=20288598

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202279A SE0202279D0 (sv) 2002-07-19 2002-07-19 Novel comppounds

Country Status (9)

Country Link
US (1) US20050203172A1 (es)
EP (1) EP1539731B9 (es)
JP (1) JP2006504655A (es)
AT (1) ATE382616T1 (es)
AU (1) AU2003245230A1 (es)
DE (1) DE60318459T2 (es)
ES (1) ES2297174T3 (es)
SE (1) SE0202279D0 (es)
WO (1) WO2004009580A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201512635D0 (en) 2015-07-17 2015-08-26 Ucl Business Plc Uses of therapeutic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902710A (en) * 1988-12-14 1990-02-20 Eli Lilly And Company Serotonin and norepinephrine uptake inhibitors
GB0004149D0 (en) * 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel compounds
GB0004153D0 (en) * 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
AU6950301A (en) * 2000-07-13 2002-01-30 Sankyo Co Amino alcohol derivatives
ES2315430T3 (es) * 2001-10-04 2009-04-01 Smithkline Beecham Corporation Inhibidores de nf-kb.

Also Published As

Publication number Publication date
WO2004009580A1 (en) 2004-01-29
EP1539731B9 (en) 2008-08-20
US20050203172A1 (en) 2005-09-15
ATE382616T1 (de) 2008-01-15
DE60318459D1 (de) 2008-02-14
EP1539731B1 (en) 2008-01-02
JP2006504655A (ja) 2006-02-09
ES2297174T3 (es) 2008-05-01
EP1539731A1 (en) 2005-06-15
AU2003245230A1 (en) 2004-02-09
DE60318459T2 (de) 2008-12-11

Similar Documents

Publication Publication Date Title
MXPA03010142A (es) Nuevos derivados de arilheteroalquilamina.
SE0202463D0 (sv) Novel compounds
UA84175C2 (ru) Гетероциклические ингибиторы мэк и их применение
SE0101387D0 (sv) Novel compounds
HK1089163A1 (en) Quinoxaline derivatives as neutrophil elastase inhibitors and their use
ATE331711T1 (de) Entzündungshemmende 3-arylthio-3- thiazolylalkylamine
SE9803518D0 (sv) Novel compounds
SE0302323D0 (sv) Novel compounds
GB0314967D0 (en) Piperazine derivatives
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE9803773D0 (sv) Compounds
SE0302756D0 (sv) Novel Compounds
SE0102641D0 (sv) Novel compounds
GB0004152D0 (en) Novel compounds
SE0102639D0 (sv) Novel compounds
SE0202280D0 (sv) Novel compounds
SE0102640D0 (sv) Novel compounds
SE0103325D0 (sv) Novel compounds
SE0300907D0 (sv) Novel compounds
SE0202279D0 (sv) Novel comppounds
SE0300906D0 (sv) Novel compounds
SE9901530D0 (sv) Novel compounds
SE9802650D0 (sv) Compounds
SE0303075D0 (sv) 4-substituted imidazoles
SE0301698D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof